Nav: Home

Next-generation metabolomics may facilitate the discovery of new antidepressants

August 06, 2018

Depression is one of the most common diseases that affects at least 4.4% of the world population since 2015. Current antidepressants are limited by their undesirable side effects and slow onset. The development of drugs for depression is particularly challenging due to the complexity of the symptoms, heterogeneity and comorbid diagnosis. Indeed, only one new drug was approved for the treatment of depression by the US FDA in the last 10 years (2008-2018). More efforts are urgently needed to enhance the productivity and creativity of the discovery and development (R&D) of new antidepressants

The origins of metabolomics can be traced back to the newborn screening of inborn errors of metabolism in clinical chemistry since the 1960s, which was much earlier than genomics and proteomics. With the advancements of separation and mass spectrometry detection techniques, metabolomics is entering into a new era in which researchers can gain more insights about metabolic pathways and their significance in health and disease.

Dr. Kefeng Li from the University of California, San Diego, (UCSD, San Diego, CA, USA) has been working in the field of metabolomics for years. In this paper, he and the colleagues summarized the analytical platforms for NGM and its main applications in antidepressants R&D. These platforms provide broad coverage of different classes of metabolites, superior detection sensitivity, high resolution and mass accuracy. Because of these advantages, NGM has demonstrated great potential in all the stages of pharmaceutical R&D.

Dr. Li, the corresponding author of the paper comments, "We specifically selected albiflorin, a botanical medicine isolated from Peony to demonstrate the practical utility of NGM". Natural products tend to have multiple targets and unpredictable toxicity. NGM analysis showed the potential antidepressant targets of albiflorin. NGM also confirmed the low toxicity of albiflorin. It might need over 5 years of work using traditional approaches to come up with the same conclusion that only needs 1-2 years for NGM. NMG really speeds up the development of albiflorin as a new class of antidepressant. Dr. Li adds, "Albiflorin is a very promising multi-target drug candidate with a low toxic profile, which overcomes the side effects of some of the current commonly used antidepressants".

In regarding to the future of NGM, Dr. Li underlines that "The bottlenecks of metabolomics have still not been completely solved. Standardization of metabolomic procedures and understanding the biology behind metabolomic big data are required to be further studied."
-end-
For more information, please visit: http://www.eurekaselect.com/164079

Bentham Science Publishers

Related Depression Articles:

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.
Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.
Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.
Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.
Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.
CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.
Post-natal depression in dads linked to depression in their teenage daughters
Fathers as well as mothers can experience post-natal depression -- and it is linked to emotional problems for their teenage daughters, new research has found.
Being overweight likely to cause depression, even without health complications
A largescale genomic analysis has found the strongest evidence yet that being overweight causes depression, even in the absence of other health problems.
Don't let depression keep you from exercising
Exercise may be just as crucial to a depression patient's good health as finding an effective antidepressant.
Having an abortion does not lead to depression
Having an abortion does not increase a woman's risk for depression, according to a new University of Maryland School of Public Health-led study of nearly 400,000 women.
More Depression News and Depression Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.